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Objectives This study sought to assess the value of left ventricular (LV) endocardial unipolar electroanatomical mapping
(EAM) in identifying irreversibility of LV systolic dysfunction in patients with left ventricular nonischemic cardio-
myopathy (LVCM).
Background Identifying irreversibility of LVCM would be helpful but cannot be reliably accomplished by bipolar EAM or car-
diac magnetic resonance identification of macroscopic scar.
Methods Detailed endocardial LV EAM was performed in 3 groups: 1) 24 patients with irreversible LVCM (I-LVCM) but with
no or minimal macroscopic scar (15% LV surface) evidenced on bipolar voltage EAM and/or cardiac magnetic
resonance; 2) 14 patients with reversible ventricular premature depolarization–mediated LVCM (R-LVCM); and 3)
17 patients with structurally normal hearts. LV endocardial unipolar electrogram amplitude and area of unipolar
amplitude abnormality were defined after excluding macroscopic scar.
Results Unipolar amplitude differed in the 3 groups: median of 7.6 (interquartile range [IQR]: 5.5 to 9.7) mV in I-LVCM
group, 13.2 (IQR: 10.4 to 16.2) mV in R-LVCM group, and 16.3 (IQR: 13.6 to 19.8) mV in structurally normal
hearts group (p  0.001). Areas of unipolar abnormality represented a large proportion of total LV surface in
I-LVCM, 64.7% (IQR: 47.5% to 75.9%) compared with R-LVCM, 5.2% (IQR: 0.0% to 19.1%) and structurally nor-
mal hearts, 0.1% (IQR: 0.0% to 0.9%), groups (p  0.001). A unipolar abnormality area cutoff of 32% of total LV
surface was 96% sensitive and 100% specific in identifying irreversible cardiomyopathy among patients with LV
dysfunction (I-LVCM and R-LVCM), p  0.001.
Conclusions Detailed unipolar voltage mapping can identify irreversible myocardial dysfunction consistent with fibrosis, even
in the absence of bipolar EAM or cardiac magnetic resonance abnormalities, and may serve as valuable prog-
nostic tool in patients presenting with LVCM to facilitate clinical decision making. (J Am Coll Cardiol 2012;60:
2194–204) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.977Risk stratification in nonischemic left ventricular dilated car-
diomyopathy (LVCM) remains challenging. The identifica-
tion of irreversibility of LVCM could help establish prognosis,
predict response to therapies to improve left ventricular (LV)
From the Electrophysiology Section, Cardiovascular Division, Department of Med-
icine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Sup-
ported in part by the F. Harlan Batrus Research Fund and the Susan and Murray
Bloom Research Fund. Dr. Marchlinski has received research grant support and
lecture honoraria from Biosense Webster on topics unrelated to the content of this
study. Dr. Gerstenfeld has received research support from Biosense Webster. Dr.
Callans is a consultant to Biosense Webster. Dr. Cooper has received honoraria from
Medtronic, Boston Scientific, St. Jude Medical, Biotronik, and Spectranetics. All
other authors have reported that they have no relationships relevant to the contents of
this paper to disclose.Manuscript received January 30, 2012; revised manuscript received July 18, 2012,
accepted August 19, 2012.function, and determine necessity for implantable cardioverter-
defibrillator (ICD) implant.
Macroscopic scar suggested by bipolar voltage electroana-
tomic mapping (EAM) and cardiac magnetic resonance
(CMR) imaging can be identified only in a minority of
patients with LVCM and, when present, frequently its size
does not correlate with the degree of global LV systolic
dysfunction (1,2). An alternative explanation for persistent
impairment of LV function in this setting may be diffuse
microfibrosis (3,4).
The purpose of this study was to determine, in patients
with LVCM, whether unipolar voltage mapping is useful
for identifying myocardium demonstrating irreversible car-
diomyopathy in the absence of bipolar electrogram or CMR
evidence of macroscopic scar.
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Study population. We examined patients undergoing cath-
ter ablation of symptomatic ventricular premature depolariza-
ion (VPD) or ventricular tachycardia (VT) at the Hospital of
he University of Pennsylvania from January 2003 to January
011. All procedures were performed following the institu-
ional guidelines of the University of Pennsylvania Health
ystem and all patients provided written informed consent.
etailed LV electroanatomical data were obtained from: 1)
atients with irreversible LVCM; and 2 reference groups: 2)
atients with reversible VPD-mediated LV cardiomyopathy;
nd 3) patients with structurally normal hearts (SNH).
IRREVERSIBLE LVCM. Twenty-four patients (23 men, mean
ge: 61  13 years, LV ejection fraction [LVEF]: 28  9%)
ith idiopathic irreversible LVCM (I-LVCM) who under-
ent catheter ablation of sustained VT (22 patients) or
requent symptomatic VPD (2 patients). The diagnosis of
-LVCM was established by a persistent global LVEF 35%
r an improvement 10% after 2 years of follow-up under
ptimal medical therapy, in the absence of potentially revers-
ble cause, prior myocardial infarction, significant stenosis
75%) of major epicardial coronary arteries, or significant
rimary valvular abnormalities. Other causes of dilated cardio-
yopathy were excluded. To identify a group with probable
xtensive microscopic but not extensive macroscopic scar, all
atients in the I-LVCM group had to demonstrate diffuse
ecrease in wall motion but 15% of identifiable endocardial
ENDO) and/or epicardial (EPI) surface manifesting conflu-
nt low bipolar voltage abnormalities (1.5 mV for ENDO
nd 1.0 mV for EPI) (5,6). CMR imaging was also used,
hen possible, to identify sizeable intramural or EPI macro-
copic scar. The 24 patients were identified after excluding
hose from a larger group of 156 patients with LVCM who
ither had 15% LV ENDO or EPI surface area with
onfluent bipolar voltage abnormalities or incomplete voltage
aps.
REVERSIBLE LVCM. Fourteen patients (9 men, mean age:
2  21 years, LVEF: 31  10%) with reversible VPD-
induced LV cardiomyopathy (R-LVCM) and LV systolic
dysfunction at the time of detailed ENDO EAM served as
1 reference group to define the specificity of the observa-
tions. Documented VPD burden was 20% or 20,000/24 h
in all cases. Catheter ablation alone was effective in elimi-
nating VPD in 10 of 14 patients. In the remaining 4
patients, VPD elimination was achieved with adjunctive
medical therapy. The diagnosis of R-LVCM was estab-
lished by the normalization of LV systolic function (LVEF
50% after treatment and improvement 10% from base-
line) and absence of coronary or valvular heart disease.
STRUCTURALLY NORMAL HEART. Seventeen patients (13
en, mean age: 41  11 years, LVEF 55%) with SNH
ho underwent detailed ENDO LV mapping and catheter
blation of idiopathic VPD/VT served as the second refer- gnce group. Absence of structural
eart disease was confirmed with
ransthoracic echocardiography,
tress testing, and/or coronary
ngiography.
ardiac imaging. All patients
nderwent transthoracic echocar-
iography at the time of the pro-
edure. LVEF, LV end-diastolic
iameter, LV end-systolic diame-
er, interventricular septal and LV
osterior wall thickness were eval-
ated. CMR imaging was per-
ormed to further define the pres-
nce of macroscopic scar in
elected patients (within 3 months
f ablation procedure). CMR was
erformed on a 1.5-T scanner
Avanto, Siemens, Erlangen, Ger-
any) using a standard protocol that
ncluded assessment of delayed gad-
linium enhancement. To reduce
he risk of radiofrequency-related
eating of the intracardiac lead in
atients with ICDS, a non-balanced
cho sequence (TurboFLASH) was
sed for cine imaging to reduce
nergy deposition and device ar-
ifacts (7).
ndocardial mapping. De-
ailed maps of the ENDO LV
urface were obtained during si-
us rhythm or ventricular pacing
sing the CARTO EAM system
Biosense Webster Inc., Dia-
ond Bar, California) and a 4-mm
tandard tip catheter (NaviStar, Bio-
ense Webster Inc.) or 3.5-mm open irrigated-tip catheter
Navistar Thermocool, BiosenseWebster Inc.). Bipolar (bandpass
ltered at 30 to 500 Hz) and unipolar (bandpass filtered at 1 to
40 Hz) electrograms were recorded and displayed at 200
m/s sweep speed. Wilson central terminal was used as an
ndifferent electrode to record unipolar electrograms. A de-
ailed assessment of individual electrogram characteristics was
ade off-line before being displayed as 3-dimensional voltage
aps to: 1) ensure a correct measurement of peak-to-peak
oltage amplitude; 2) avoid the repolarization signal on unipo-
ar electrograms; and 3) exclude noise and pacing artifact. To
nsure adequate sampling density and a complete representa-
ion of voltage distribution, a fill threshold of 20 mm was
aintained. Valvular sites were identified and intracavitary
oints with poor contact were edited and excluded.
picardial mapping. EPI mapping was performed at the
ecision of the primary operator and based on clinical criteria
uch as characteristics of VT on surface 12-lead electrocardio-
Abbreviations
and Acronyms
AUA  area(s) of unipolar
voltage abnormality
CMR  cardiac magnetic
resonance
EAM  electroanatomical
mapping
ENDO  endocardial
EPI  epicardial
ICD  implantable
cardioverter-defibrillator
I-LVCM  irreversible
nonischemic left
ventricular–dilated
cardiomyopathy
IQR  interquartile range
LV  left ventricle
LVCM  nonischemic left
ventricular–dilated
cardiomyopathy
LVEF  left ventricle
ejection fraction
R-LVCM  reversible
ventricular premature
depolarization–mediated
nonischemic left
ventricular–dilated
cardiomyopathy
ROC  receiver-operating
characteristic
SNH  structurally normal
heart(s)
VPD  ventricular
premature depolarization(s)
VT  ventricular
tachycardiaram !----and/or failure of prior ENDO ablation. EPI
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scribed by Sosa et al. (8). A 4-mm standard tip or 3.5-mm
open irrigated-tip catheter was also used. The fill threshold
was maintained at 20 mm and all aspects of the LV EPI
were sampled.
Reference values for bipolar mapping. Abnormal LV
bipolar signal amplitude was identified according to previously
established criteria for ENDO (1.5 mV) and EPI ( 1.0
V) (5,6). To avoid overestimation of EPI scar due to areas of
normal” fat distribution, confluent areas of low bipolar voltage
1.0 mV) also had to demonstrate 20% abnormal electro-
rams including: 1) wide,80 ms duration; 2) split, 2 or more
istinct components with20 ms isoelectric segment between
eaks of individual components; or 3) late, distinct electro-
rams with onset after the end of the QRS complex (6).
efining area of interest by excluding areas with bipolar
oltage and CMR abnormalities. The area of interest for
he study was the LV ENDO surface on the electroanat-
mical map with no evidence of macroscopic scar according
o bipolar voltage EAM (ENDO or opposite EPI) and/or
Figure 1 Delineation of Area of Interest Excluding Area of Bipo
Left posterior oblique views showing area of bipolar voltage abnormality on left ve
endocardial (ENDO) map (B) using the mesh feature on the CARTO software (C).
cal (wide, split, or late) electrogram abnormalities (yellow tags). The LV ENDO dirMR criteria. Confluent areas (2 cm2) of bipolar electro-
gram abnormality were identified on the LV ENDO and
EPI electroanatomical maps. When detected, the area of
bipolar abnormality on the epicardium was projected on the
endocardium using the CARTO software mesh feature
(Fig. 1). If CMR was available, areas of delayed gadolinium
enhancement consistent with macroscopic scar were also
identified and located on the LV ENDO electroanatomical
map using the standardized myocardial 17-segment model
(9) (Fig. 2). The aggregate of probable macroscopic scar
areas on the LV ENDO map thus defined was excluded,
leaving the remaining larger area of myocardium as the area
of interest for further signal analysis (Fig. 3).
The area of probable macroscopic fibrosis on the LV
ENDO map according to the defined criteria was measured
and its proportion to the total LV ENDO area calculated.
As the purpose of the study was the evaluation of dysfunc-
tional but otherwise “normal” myocardium according to
bipolar voltage EAM and CMR imaging criteria, patients
car on EPI Map
r (LV) epicardial (EPI) electroanatomical map (A), which is projected on the LV
of EPI “scar” had to demonstrate low bipolar voltage (1.0 mV) and morphologi-
pposite to bipolar EPI scar was excluded from the unipolar analysis.lar S
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LV ENDO map were not included.
Unipolar reference cutoff value and electrogram analysis. Uni-
polar voltage amplitudes of LV ENDO electrograms within
the area of interest as defined were analyzed. Abnormal LV
ENDO unipolar signal amplitude was defined as 8.27 mV,
ased on previously published criteria (10). To further maxi-
ize specificity of unipolar recordings for identifying abnormal
yocardium, points within 1 cm around the mitral annulus
nd within 1 cm around areas of probable macroscopic scar
according to EAM and/or CMR criteria) were excluded (Fig.
). Differences in unipolar electrogram amplitude distributions
mong the 3 groups were evaluated. A receiver-operating
haracteristic (ROC) analysis was performed to evaluate the
bility of the 8.27-mV cutoff value to identify amplitude
ifferences between the groups.
ssessment of unipolar low voltage region. The extent of
Figure 2 Delineation of Area of Interest Excluding Area of DGE
Basal short-axis (A) and 2-chamber long-axis (B) images from a cardiac magnetic
in the basal anterior segment (segment 1) (C). The whole segment is considered
lined in green, in order to be excluded from the unipolar electrogram analysis. Abbonfluent areas of unipolar voltage abnormality (AUA) was dlso measured within the area of interest using the software and
easurement algorithm included in the CARTO system. The
ercent AUA of the total ENDO LV surface area was
etermined and compared among the 3 study groups. Two
ndependent observers analyzed the AUA and the interob-
erver variability of these measurements was evaluated.
tatistical analysis. Continuous data are expressed as
ean  SD or median (interquartile range) when appro-
riate. All continuous data were tested using the 1-sample
olmogorov-Smirnov test against a normal distribution.
ne-way analysis of variance was used for comparisons of
ormally distributed continuous variables among the 3
roups. When appropriate, further post-hoc subgroup anal-
sis was performed using the Tukey correction. Compari-
ons of non-normally distributed continuous variables
mong the 3 groups were performed using the Kruskal-
allis test. Differences in unipolar electrogram amplitude
MR
nce (CMR) study. The area of delayed gadolinium enhancement (DGE) is located
scopic scar and projected on the LV ENDO electroanatomical map (D, E), out-
ions as in Figure 1.on C
resona
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reviatistributions were also evaluated using the Kolmogorov-
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amplitude and percent AUA was evaluated with ROC
analysis. Multiple linear regression was used to examine the
relation between percent AUA and irreversibility, adjusting
for age, sex, presence of antiarrhythmic drugs at the time of
procedure, and LV size. The intraclass correlation coeffi-
cient was used to measure the degree of agreement between
2 independent observers, assuming a 2-way random model
with absolute agreement. For comparison of noncontinuous
variables, the chi-square test was used. A p value 0.05 was
considered statistically significant.
Results
Patient characteristics. Baseline characteristics of the 55
patients in the study are listed in Table 1. Patients in the
I-LVCM group were older (61  13 years) than those in
he R-LVCM (42  21 years) and SNH groups (41  11
ears) (p  0.01). Female prevalence was also lower in the
-LVCM group (4%) than in the R-LVCM (36%) and
NH (23%) groups (p  0.04). Presence of antiarrhythmic
rugs at the time of procedure was significantly higher in the
-LVCM group (p  0.01). Mean New York Heart Associ-
tion functional class was similar in the groups of patients with
V systolic dysfunction: 1.6 0.8 in the R-LVCM group and
Figure 3 Delineation of Area of Interest After Exclusion of Peri
Right anterior (A) and left posterior oblique (B) of a LV ENDO bipolar map are sho
of basal lateral macroscopic scar (blue dots) and within 1 cm around the mitral a
outside squat arrows) comprises the remaining LV surface used for the unipolar s.1  0.9 in the I-LVCM group (p  0.12). achocardiographic findings. Main echocardiographic
ndings are listed in Table 1. Groups with irreversible and
eversible LVCM exhibited no difference in the degree of
V systolic dysfunction (LVEF: 28  9 vs. 31  10%; p 
.33) at the time of the procedure. LV size was larger in the
-LVCM group, reflected by greater LV end-diastolic
iameter (66  8 mm vs. 54  7 mm; p 0.01) and LV
nd-systolic diameter (56  10 mm vs. 44  7 mm; p 
.01), than in the R-LVCM group. There were no signif-
cant differences in LV wall thickness between the groups
mean interventricular septal and posterior wall size: 10.6 
.9 mm and 9.8  1.7 mm in the I-LVCM group; 9.9 
.8 mm and 9.4  1.7 mm in the R-LVCM group; and
.8 1.5 and 9.7 1.7 mm in the SNH group; p 0.49 and
.79, respectively). Eight patients (33%) in the I-LVCMgroup
nd 2 (14%) in the R-LVCM group exhibited some degree of
V hypertrophy (all mild except 1 moderate in the I-LVCM
roup). All patients in the SNH group exhibited normal LV
ize and function and normal wall thickness.
A moderate negative correlation between LV chamber size
nd LV function was found among patients with LV systolic
ysfunction, I-LVCM and R-LVCMgroups (r0.58, p
.001). A moderate significant correlation between LV cham-
er size and irreversibility of LV function was also found
lar Region and Area of Probable Macroscopic Scar
maximize specificity of unipolar recordings, points within 1 cm around the area
(white dots) were excluded (inside squat arrows). The area of interest (purple
amplitude analysis. Abbreviations as in Figure 1.valvu
wn. To
nnulus
ignalmong patients in these groups (r  0.59, p  0.001).
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patients underwent detailed LV ENDO EAM (189  99
oints sampled). Twenty-two patients (40%) also under-
ent detailed EPI EAM (409  184 points): 17 (71%) in
he I-LVCM group; 2 (14%) in the R-LVCM group; and
(18%) in the SNH group. CMR was available in 19
atients (34%): 7 (29%) in the I-LVCM group; 9 (64%) in
he R-LVCM group; and 3 (18%) patients in the SNH
roup. Overall, 19 patients (79%) in the I-LVCM group
nd 9 patients (64%) in the R-LVCM underwent EPI
AM and/or CMR in addition to ENDO EAM.
An area of probable macroscopic scar, based on either
NDO  EPI bipolar voltage EAM and/or CMR criteria,
as present in 22 patients (92%) with I-LVCM and occupied
mean ENDO area of 20.4  13.1 cm2, which represented
8.6  4.7% (range 0% to 14.8%) of total LV ENDO surface
area. In the R-LVCM group, an area of probable macroscopic
scar was present in 6 patients (43%), with a mean area of 4.1
6.9 cm2, which represented 2.7 3.9% (range 0% to 10.5%) of
LV surface area. The proportional area of macroscopic scar was
Baseline Characteristics of Patients in the 3 GrTable 1 Baseline Characteristics of Patient
I-LVCM
Patients 24
Male 23 (96)
Age, yrs 61 13
LVEF, % 28 9
LVEDD, mm 66 8
IVS size, mm 10.6 1.9
PW size, mm 9.8 1.7
AAD at procedure 19 (79)
ICD 23 (96)
Epicardial mapping 17 (71)
CMR 7 (29)
Values are n, n (%), or mean SD. *Statistical evaluation of difference
groups).
AAD antiarrhythmic drug; CMR cardiac magnetic resonance; IC
left ventricular–dilated cardiomyopathy; IVS  interventricular septum
left ventricular ejection fraction; PW  posterior wall; R-LVCM  r
ventricular–dilated cardiomyopathy; SNH  structurally normal heart(
Main Findings on LV EAMTable 2 Main Findings on LV EAM
LV endocardial mapping points, n
Points within the area of interest, n
EAM in sinus rhythm 2
Unipolar electrogram amplitude, mV 7.
Area of probable macroscopic scar, cm2 2
Percent area of probable macroscopic scar, %
Area of unipolar voltage abnormality, 8.27 mV, cm2 137.
[
Percent area of unipolar voltage abnormality, 8.27 mV, % 64.
[Values are mean  SD, n (%), median (interquartile range), or [global range].
EAM  electroanatomical mapping; other abbreviations as in Table 1.significantly larger in the I-LVCM group than in the
R-LVCM group (p  0.001). However, when present, the
total area of macroscopic scar was 15% of the LV ENDO
surface area in all cases, which is consistent with described
study entry criteria. None of the 17 patients in SNH group
exhibited any area macroscopic scar.
Unipolar electrogram analysis. A total of 7,514 LV
ENDO recordings were obtained from the area of interest:
4,148 recordings in the I-LVCM group; 1,342 in the
R-LVCM group; and 2,024 in the SNH group. Main
findings of LV EAM are summarized in Table 2. The
unipolar signal amplitude was lower in the I-LVCM group
(median: 7.6 mV [interquartile range (IQR): 5.5 to 9.7])
than in the R-LVCM (median: 13.2 mV [IQR: 10.4 to 16.2
mV]) and SNH groups (median: 16.3 mV [IQR: 13.6 to
19.8 mV]) (p  0.001). The shift in unipolar voltage
istribution observed in the I-LVCM group was also reflected
y an increase in distribution skewness, from 0.38  0.05 and
0.30 0.07 in the SNH and R-LVCM groups to 0.72 0.04
n the I-LVCM group (p  0.001) (Fig. 4).
he 3 Groups
-LVCM SNH p Value
14 17
9 (64) 13 (76) 0.04
2 21 41 11 0.01
1 10 55 0.33*
4 7 49 5 0.01
9 1.8 9.8 1.5 0.49
4 1.7 9.7 1.7 0.79
4 (29) 2 (12) 0.01
6 (43) 1 (6)
2 (14) 3 (18)
9 (64) 3 (18)
among patients with LV systolic dysfunction (only I-LVCM and R-LVCM
plantable cardioverter-defibrillator; I-LVCM irreversible nonischemic
left ventricle; LVEDD  left ventricular end-diastolic diameter; LVEF 
le ventricular premature depolarization&mediated nonischemic left
M R-LVCM SNH
115 139 41 142 57
69 102 37 119 58
) 14 (100) 17 (100)
9.7) 13.2 (10.4–16.2) 16.3 (13.6–19.8)
13.1 4.1 6.9 0.0
6.7] [0.0–23.8] [0.0–0.0]
4.7 2.7 3.9 0.0 0.0
4.8] [0.0–10.5] [0.0–0.0]
.1–184.3) 5.2 (0.0–31.0) 0.1 (0.0–1.4)
17.8] [0.0–36.9] [0.0–14.5]
–75.9) 5.2 (0.0–19.1) 0.1 (0.0–0.9)
88.4] [0.0–29.7] [0.0–8.6]oupss in t
R
4
3
5
9.
9.
in LVEF
D im
; LV I-LVC
249
174
2 (91.7
6 (5.5–
0.4
[0.0–4
8.6
[0.0–1
3 (106
47.4–2
7 (47.5
25.2–
Qg
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New Criteria to Identify Irreversible Cardiomyopathy November 20/27, 2012:2194–204Low unipolar amplitude, 8.27 mV, was identified in
2,437 (58.8%) signals in the I-LVCM group, 132 (9.8%) in
the R-LVCM group, and 24 (1.2%) in the SNH group. The
ROC analysis for unipolar electrogram amplitude in patients
with LV systolic dysfunction (R-LVCM and I-LVCM
groups) showed an area under the curve of 86.1% and dem-
onstrated that the 8.27-mV amplitude cutoff had a 58.9%
sensitivity and 90.2% specificity for detecting an AUA related
to irreversibility of LV dysfunction (p  0.001).
uantitative assessment of AUA. AUA 5 cm2 in size
were present in 24 of 24 patients (100%) in the I-LVCM
group, 7 of 14 (50%) in the R-LVCM group, and 1 of 17 (6%)
in the SNH group (Table 2). Median unipolar signal ampli-
tude within AUA (8.27 mV) was smaller in the I-LVCM
roup (5.84  1.61 mV) than in the R-LVCM (7.17  1.00
mV) and SNH (7.47  1.07 mV) groups (p  0.001).
The percent AUA represented a larger proportion of the
total LV ENDO surface area in the I-LVCM group (median:
64.7% [IQR: 47.5% to 75.9%]) than in the R-LVCM (me-
dian: 5.2% [IQR: 0.0% to 19.1%]) and SNH (median: 0.1%
[IQR: 0.0% to 0.9%]) groups (p  0.001). There was no
significant difference in percent AUA between the R-LVCM
and SNH groups (p  0.26) (Figs. 5 and 6). The ROC
analysis for the percent AUA among patients with LV systolic
dysfunction (I-LVCM and R-LVCMgroups) showed an area
under the curve of 99.7% and indicated that a 32% cutoff
value for the percent AUA is 96% sensitive and 100%
specific for identifying irreversibility of LV dysfunction (p
0.001) (Fig. 7). The intraclass correlation coefficient for
AUA measurement was 1.00 (range 0.99 to 1.00), suggest-
ing low interobserver variability.
Because of the demonstrated differences in the groups
with respect to age, sex, presence of antiarrhythmic drugs,
and LV size (LV end-diastolic diameter), a further analysis
with multiple linear regression was performed to evaluate
their effect on the unipolar voltage findings in patients with
low LVEF (R-LVCM and I-LVCM groups). This analysis
found that only irreversibility of LVCM was an independent
predictor of a higher percent AUA (p  0.001). Sex, presence
of antiarrhythmic drugs, and LV size were not independent
predictors on multivariate analysis (p  0.89, 0.38, and 0.95,
respectively). Interestingly, this analysis found a trend of older
age predicting larger percent AUA (p  0.09).
An additional subgroup analysis based on age was per-
formed to further evaluate its effect on percent AUA among
patients with low LVEF (R-LVCM and I-LVCM groups).
In patients below 65 years of age, the median percent AUA
was 51.0% (IQR: 41.1% to 74.3%) in the I-LVCM group
and 2.7% (IQR: 0.0% to8.9%) in the R-LVCM group. In
patients above 65 years of age, the median percent AUA was
69.6% (IQR: 55.7% to 76.8%) in the I-LVCM group and
19.5% (IQR: 19.2% to 24.6%) in the R-LVCM group.
According to these findings, the analysis based on age
adjusting the previous 32% cutoff of percent AUA to 22%
for younger patients (65 years) and to 35% for older patientsFigure 4 Distribution of the Unipolar EGM Amplitudes
(A) Irreversible nonischemic left ventricular–dilated cardiomyopathy (I-LVCM)
group. (B) Reversible ventricular premature depolarization&mediated nonisch-
emic left ventricular–dilated cardiomyopathy (R-LVCM) group. (C) Structurally
normal heart (SNH) group. Using the 8.27-mV reference value for identifying
normal unipolar signal amplitude, 58.8% of unipolar electrograms (EGM) were
identified as abnormal in the I-LVCM group, 9.8% in the R-LVCM group, and
1.2% in the SNH group. Amplitude is expressed as median (interquartile range)
millivolts.(65 years) demonstrated a 100% sensitivity and 100% spec-
2201JACC Vol. 60, No. 21, 2012 Campos et al.
November 20/27, 2012:2194–204 New Criteria to Identify Irreversible Cardiomyopathyificity to detect irreversibility of LV dysfunction among pa-
tients of both age-based subgroups, below and above 65 years
(p  0.001 and p  0.01, respectively) (Fig. 7).
Optimizing the cutoff value for normal LV ENDO
unipolar amplitude based on age. The ROC analysis for
unipolar electrogram amplitude estimated a 53.7% sensitiv-
Figure 5 LV Electroanatomical Voltage Maps From a Patient W
Both endocardial and epicardial bipolar voltage maps (A, B) exhibited no area of a
with no fragmented signals on the epicardial map, which is consistent with fat. On
(8.27 mV) that occupies 88.3% of the total LV endocardial surface area. LVEF 
Figure 6 LV Electroanatomical Voltage Maps From a Patient W
The bipolar endocardial map exhibited no area of voltage abnormality. The unipola
(8.27 mV) that occupied a 2.9% of the total LV endocardial surface area. VPD  veity and 94.9% specificity for the 8.27-mV cutoff when
performed in the subgroup of younger patients (65 years).
Interestingly, this age-based ROC analysis also suggested
that a higher cutoff for unipolar voltage of 9.65 mV would
increase the sensitivity to 69.9% while maintaining the same
high specificity of 90.0% to identify AUA. Using the
LVCM and Persistent LV Systolic Dysfunction (LVEF: 35%)
ality. There was a small area of low voltage (1.0 mV) in the basal lateral wall
ndocardial unipolar voltage map (C), there is a large area of voltage abnormality
entricular ejection fraction; other abbreviations as in Figures 1 and 4.
eversible VPD-Induced LVCM (LVEF: 35% at Procedure)
cardial map exhibited a small area of voltage abnormality
r premature depolarization; other abbreviations as in Figures 1, 4, and 5.ith I-
bnorm
the e
left vith R
r endo
ntricula
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age, the median percent AUA was 74.8% (IQR: 58.2% to
81.4%) in the I-LVCM group, 5.3% (IQR: 1.0% to 26.4%)
in the R-LVCM group, and 0.8% (IQR: 0% to 4.7%) in the
SNH group. Using the higher cutoff in patients 65 years
of age, the percent AUA was still 10% in 8 of 11 patients
(73%) in the R-LVCM group, whereas 54% in 12 of 13
patients (92%) in the I-LVCM group. The higher
unipolar voltage cutoff in the population 65 years of age
Figure 7 Percent Area of Unipolar Abnormality (<8.27 mV) to
(A) All 3 study groups of patients (I-LVCM, R-LVCM, and SNH), (B) patients 65 y
Among patients with LV systolic dysfunction (I-LVCM and R-LVCM groups), a cutoff
96% sensitive and 100% specific in identifying irreversibility of LVCM (p  0.001)
years (B) and higher to 35% for patients 65 years (C). Both age-adjusted cutoff
(p  0.001 and p  0.01, respectively). Abbreviations as in Figures 1 and 4.provided a greater potential for discrimination betweenthe I-LVCM and R-LVCM groups, with a larger differ-
ence between the ranges of percent AUA, while main-
taining no difference between the R-LVCM and SNH
group (p  0.18) (Fig. 8).
Discussion
This study demonstrates the ability of ENDO unipolar
voltage EAM, 8.27 mV, to identify permanent LV
LV Endocardial Surface Area in the Study Population
ith I-LVCM and R-LVCM, and (C) patients 65 years with I-LVCM and R-LVCM.
f 32% for the percent area of unipolar voltage abnormality (AUA) proved to be
he age-based analysis shifted the 32% cutoff lower to 22% for patients 65
onstrated 100% sensitivity and 100% specificity to detect irreversibility of LVCMTotal
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progressive shift in the median amplitude of unipolar LV
ENDO electrograms from patients without structural heart
disease, 16.3 mV, to those with reversible, 13.2 mV, and
irreversible, 7.6 mV, LVCM. Patients with I-LVCM dem-
onstrated confluent low unipolar voltage areas comprising a
median of 64.7% (IQR: 47.5% to 75.9%) of the total LV
ENDO surface. In contrast, patients with R-LVCM and
comparable LV systolic dysfunction at the time of EAM
and patients with SNH exhibited either an absence of or
smaller AUA on the LV ENDOmaps: median: 5.2% (IQR:
0.0% to 19.1%) in the R-LVCM group; and 0.1% (IQR:
0.0% to 0.9%) in the SNH group. A cutoff AUA of 32%
of total ENDO surface area accurately identified irrevers-
ibility of LVCM in patients with systolic dysfunction.
Using an 8.27-mV reference value, we have recently
shown that unipolar ENDO LV EAM can help identify
EPI bipolar low voltage consistent with macroscopic scar-
ring in patients with LVCM and normal ENDO bipolar
voltage (10). It appears that the presence of an AUA not
correlating with ENDO or EPI scar and the finding of a
significantly lower mean unipolar signal amplitude in the
LV of patients with LVCM compared with those without
heart disease suggest that the larger “antenna” of unipolar
electrograms could also detect a more diffuse underlying
myocardial process with persistent LV dysfunction. More-
over, an inverse relation between amplitude of unipolar
endocardial recordings and myocardial fibrosis burden has
been already described in an experimental model of non-
Figure 8 Percent Area of Unipolar Abnormality to Total LV Endo
Patients <65 Years of Age in the 3 Study Groups (I-L
(A) Using the 8.27-mV cutoff. (B) Using the 9.65-mV cutoff. The use of a higher r
ence between the size of abnormal areas between the I-LVCM and R-LVCM groups
detected was still 10% in 8 of 11 patients (73%) 65 years in the R-LVCM grou
tions as in Figure 4.ischemic cardiomyopathy (11). In the absence of macro- cscopic fibrosis, diffuse microscopic fibrosis may explain the
permanent impairment of LV function in the setting of
LVCM. Based on findings described in previous anatomic
studies, we assert that a marked unipolar abnormality (8.27
V), in the absence of macroscopic scar, is consistent with a
arger degree of myocardial damage and diffuse microscopic
brosis (3,4). Interestingly, the use of a higher cutoff at 9.65
V would further optimize unipolar signal amplitude discrim-
nation in younger patients (65 years), providing greater
ensitivity and still being specific for detecting abnormalities
ssociated with irreversibility in LV dysfunction and probable
brosis. The reason why age may have an effect on unipolar
lectrograms remains unknown and could be due to some
egree of age-related fibrosis in older patients.
The ability of unipolar electrograms to identify irrevers-
bility of LV systolic dysfunction in this setting has impor-
ant clinical implications and may potentially assist clini-
ians in assessing sudden cardiac death risk and the need for
CD implant. In our study, 4 of 6 patients with R-LVCM
ad an ICD implanted based on a primary prevention indica-
ion because of severe LV systolic dysfunction in the absence of
ustained ventricular arrhythmias. The identification of the
otential for recovery of LV function in these 4 patients based
n the presence of limited unipolar electrogram abnormalities
ould have been helpful for better risk stratification and
voiding unneeded ICD implantation. Moreover, a better
uantification of LV myocardial fibrosis burden provided by
V ENDO unipolar signals, and not possible with other
ial Surface Area in
, R-LVCM, and SNH)
ce value for unipolar electrogram amplitude (9.65 mV) provided a larger differ-
e difference from 5.9% to 12.1%). Using this cutoff, the area of abnormality
reas 54% in 12 of 13 patients (92%) 65 years in the I-LVCM group. Abbrevia-card
VCM
eferen
(rang
p, wheurrent techniques, might potentially help in predicting re-
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the setting of LVCM and warrant additional study.
Study limitations. The study population underwent EAM
during catheter ablation of ventricular arrhythmias. More-
over, the patients included in the I-LVCM group included
those patients with sustained VT and the R-LVCM group
included patients with premature VPD–induced cardiomy-
opathy. Thus, although hopeful, these findings might not be
extrapolated to the entire population of patients with
LVCM.
An effort was made to detect and exclude from the
analysis all areas of probable macroscopic scar using either
EAM ENDO and, when available, EPI mapping or CMR.
However, 5 patients (21%) in the I-LVCM group and 5
patients (36%) in the R-LVCM group had neither EPI
EAM nor CMR for identification of areas of probable
macroscopic scar. Importantly, the fact that these patients
did not require an epicardial approach for success of catheter
ablation of VT makes the presence of significant epicardial
macroscopic substrate less likely. Nevertheless, prospective
validation of the current findings in a cohort without a
history of VT with a lower probability of any bipolar voltage
abnormality or macroscopic scar is certainly warranted.
Furthermore, our study was an observational analysis.
However, electroanatomical data collection in patients with
ventricular arrhythmias was systematically and prospectively
performed in a detailed fashion whenever attempting to
characterize the arrhythmia substrate as an institutional
strategy, making the data robust and highly representative.
In addition, artifact from the pulse generator or lead
remains a limitation for cardiac imaging in patients with
devices to define scar, but usual location (anterior or apical)
does not generally alter image characterization at the lateral
or the septal aspect of the LV, which are common locations
for macroscopic scar in the setting of LVCM (12).
Finally, this study does not provide histopathological corre-
lation in areas of unipolar voltage abnormality. Previous studies
have described the diffuse microscopic process of myocardial
fibrosis responsible for irreversibility of LV dysfunction in the
setting of LVCM. Although our observations should be
confirmed by ongoing studies in explanted hearts, the correla-
tion of unipolar voltage abnormality and irreversibility of
LVCM suggests a probable relation to myocardial fibrosis.
Conclusions
LV unipolar voltage abnormality (32% of LV ENDO
surface area) in the absence of macroscopic scar defined by
bipolar voltage abnormality or CMR criteria suggests irre-
versibility of LV myocardial dysfunction consistent with amore diffuse microscopic fibrotic process. Detailed unipolar
voltage may serve as valuable prognostic tool in patients
with LVCM for identifying irreversible LV dysfunction and
might facilitate clinical decision making.
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